Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity-Reference-Cited by-同舟云学术

Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity

Published:2019-04 Issue:4 Volume:165 Page:751-759
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Swords Douglas S.^ORCID,Mulvihill Sean J.,Brooke Benjamin S.,Skarda David E.,Firpo Matthew A.,Scaife Courtney L.

Publisher

Elsevier BV

Subject

Surgery

Reference47 articles.

1. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma;Katz;Ann Surg Oncol,2009

2. Five-year actual overall survival in resected pancreatic cancer: A contemporary single-institution experience from a multidisciplinary perspective;Picozzi;Ann Surg Oncol,2017

3. Preoperative therapy and pancreatoduodenectomy for pancreatic ductal adenocarcinoma: A 25-year single-institution experience;Cloyd;J Gastrointest Surg,2017

4. NCCN clinical practice guidelines in oncology: Pancreatic adenocarcinoma (version 1.2018) Web site. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed 6 June 2018.

5. Potentially curable pancreatic cancer: American Society of Clinical Oncology clinical practice guideline;Khorana;J Clin Oncol,2016

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding futility in pancreaticoduodenectomy: Insights from a national cohort;Journal of Surgical Oncology;2024-07-31

2. Understanding Barriers to Guideline-Concordant Treatment in Foregut Cancer: From Data to Solutions;Annals of Surgical Oncology;2024-07-02

3. Sociodemographic variation in the utilization of minimally invasive surgical approaches for pancreatic cancer;HPB;2024-07

4. Disparities in Receipt of Adjuvant Immunotherapy among Stage III Melanoma Patients;American Journal of Clinical Oncology;2024-06-28

5. Barriers to resection following neoadjuvant chemotherapy for resectable pancreatic adenocarcinoma: A national and local perspective;Journal of Surgical Oncology;2024-06-03